How 3 innovative breast cancer research projects are paving the way for new treatments
Behind every person diagnosed with breast cancer is a team of researchers and doctors committed to helping them live longer and fuller lives. And with your support, incredible progress is being made in breast cancer research. Since 1986, the female breast cancer death rate has dropped by nearly half. This means more mothers are able to watch their children grow up and more sisters, brothers and fathers can spend time with their loved ones.
Research is vital to prolonging and enhancing the quality of life for those living with breast cancer. That’s why along with CQDM and industry partners, the Canadian Cancer Society is investing nearly $10 million to support breast cancer research!
Over the next 3 years, we will be funding 3 cutting-edge breast cancer research projects with the goal to develop state-of-the-art drugs to increase survival rates for Canadians with aggressive and hard-to-treat breast cancer. Researchers for these projects have partnered with leading industry biotech companies and together are harnessing innovative technologies to bring their discoveries to life.
Cancer research has helped improve the lives of people with cancer and has led them to live longer, fuller lives. Today, more than 60% of Canadians diagnosed with cancer will survive at least 5 years after their diagnosis. As our knowledge of cancer grows, we will make an even greater impact on Canadians affected by cancer. By investing in cutting-edge research projects like those of Dr Park, Dr Basik and Dr Nepveu, we’ll be able to further understand how to prevent, diagnose, treat and live with and beyond cancer.